| CAS # | 207121-91-3 |
| SMILES | |
| Chemical Purity | |
| Molecular Formula | C13H20N2O |
| Chemical Formula | |
| Formula Weight | 220.30 |
| Reaction | |
| Note |
$149.00
Available on backorder. No lead time available. Please request a quote.
Sku SC07-7018_100_MG
US-Strem
General Details
Physical Properties
| Purity | 98%, (99% ee) |
| Density | |
| Melting Point | |
| Boiling Point | |
| Flash Point | |
| Vapor Pressure | |
| Surface Area | |
| Pore Volume | |
| Specific Rotation |
Shipping & Stability
| Safety | Yes |
| Store Cold | |
| Dry Ice | |
| Alternative Product for Air Shipment | |
| Export Limitations | |
| Pyrophoric | |
| Hygroscopic | |
| Air Sensitive | |
| Light Sensitive | |
| Heat Sensitive | |
| Moisture Sensitive | |
| Odorous Material |
Technical Notes:
1.Pharmacological management remains the primary method to treat epilepsy and neuropathic pain. A novel class of anticonvulsants termed functionalizedamino , acids (FAAs) have been advanced. In this study, FAA derivatives have been examined from which the terminal acetyl moiety was removed and termed these
compounds primary amino acid derivatives (PAADs).
2.Primary amino acid derivatives (PAADs) (N'-benzyI 2-substituted 2-amino acetamides) are structurally
related to functionalized amino acids (FAAs) (N'-benzyI 2-substituted 2-acetamido acetamides) but differ by the absence of the terminal N-acetyl group.
References:
1.J. Med. Chem., 2011, 54, 4815-4830. 2. J. Med. Chem, 2011, 54, 6432-6442.
![(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_fcd10f4b-0d78-4927-aa2e-a0b0b74de8ed_200x200_crop_center.png?v=1758852925)
![(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin, 98%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_4b85e26e-88cc-4f82-b401-354c990a2f82_200x200_crop_center.png?v=1758852923)
![(11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_7cf1ef78-2b28-43f5-8c43-605c9f4a4f67_200x200_crop_center.png?v=1758852920)
![(6aS)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_a2a38216-629f-40ec-8972-6044403d004a_200x200_crop_center.png?v=1758852918)
![(6aR)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_9d5ed4a5-9a79-41e2-b5c9-073995e8763a_200x200_crop_center.png?v=1758852915)
![(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/807426_200x200_crop_center.png?v=1758852912)
![(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)](http://www.jk-sci.com/cdn/shop/files/789148_200x200_crop_center.png?v=1758852909)
